Imaging diagnosis and differential diagnosis of acquired immunodeficiency syndrome patients complicated pulmonary cryptococcal

Abstract

Abstract: Pulmonary cryptococcal is an important opportunistic infection and one of the important causes of death in AIDS patients. Early diagnosis and treatment are an important factor to improve the prognosis. As a non-invasive examination, imaging examination plays an important role in the early diagnosis and differential diagnosis of cryptococcal infection. There is a general understanding of the imaging changes of non-AIDS patients complicated pulmonary cryptococcal , but there are few literature reports on the imaging characteristics of AIDS patients, and so far there is no characteristic imaging performance recognized by radiologists. Through literature review, combined with the retrospective analysis of our confirmed cases of AIDS-related pulmonary cryptococcal , we found that there are still some characteristic changes, in which the single nodule with central cavity is the most common sign. Mastering these characteristics is very helpful for the early diagnosis of cryptococcal infection in AIDS patients.

Key words: Acquired immunodeficiency syndrome, Pulmonary cryptococcosis, Image characteristics, Differential diagnosis

Xu Chuanjun. Imaging diagnosis and differential diagnosis of acquired immunodeficiency syndrome patients complicated pulmonary cryptococcal[J]. Electronic Journal of Emerging Infectious Diseases, 2020, 5(1): 60-64.

References

[1] 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2018版)[J]. 新发传染病电子杂志,2019,4(2):65-84.
[2] Park BJ, Wannemuehler KA, Marston BJ, et al.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS, 2009, 23(4): 525-530.
[3] Perfect JR, Dismukes WE, Dromer F, et al.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America[J].Clin Infect Dis, 2010, 50(3): 291-322.
[4] Gassiep I, Douglas J, Emeto TI, et al.Cryptococcal infections over a 15 year period at a tertiary facility & impact of guideline management[J]. Mycoses, 2018, 61(9):633-638.
[5] 胡志亮, 魏洪霞, 池云, 等. 两性霉素B三天加量疗法在艾滋病合并隐球菌性脑膜炎中的应用[J]. 中华临床感染病杂志, 2014, 9(4): 319-323.
[6] Choi HW, Chong S, Kim MK, et al.Pulmonary cryptococcosis manifesting as diffuse air-space consolidations in an immunocompetent patient[J]. J Thorac Dis, 2017, 9(2): 138-141.
[7] 钱雪琴, 范小勇, 蒋晓飞. 墨汁染色在肺泡灌洗液隐球菌检测中的应用[J]. 中国卫生检验杂志, 2014(15):2180-2181.
[8] Sakamoto A, Hisaoka M.Pulmonary cryptococcosis mimicking a metastasis in a patient with Ewing sarcoma[J]. Respirol Case Rep, 2016, 4(5):e00181.
[9] Liang Y, Shen Y, Zhang J, et al.Pulmonary cryptococcosis among 3 immunocompetent patients misdiagnosed as bacterial pneumonia and pulmonary tuberculosis[J]. CHEST, 2016, 149(4): 114-114.
[10] Okubo Y, Wakayama M, Ohno H, et al.Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans[J]. Jpn J Infect Dis, 2013, 66(3): 216-221.
[11] Kohno S, Kakeya H, Izumikawa K, et al.Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan[J]. J Infect Chemother, 2015, 21(1): 23-30.
[12] 李宁, 李敏, 万欢英. 免疫健全与免疫缺损宿主肺隐球菌病临床对比分析[J]. 上海医学, 2013, 36(1): 38-42.
[13] Öztürk M H, Aydingöz Ü.Comparison of MR signal intensities of cerebral perivascular (Virchow-Robin) and subarachnoid spaces[J]. J Comput Assist Tomogr, 2002, 26(6): 902-904.
[14] Offiah CE, Naseer A.Spectrum of imaging appearances of intracranial cryptococcal infection in HIV/AIDS patients in the anti-retroviral therapy era[J]. Clin Radiol, 2016, 71(1): 9-17.
[15] Uicker WC, McCracken JP, Buchanan KL. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system[J]. Sabouraudia, 2006, 44(1): 1-11.
[16] Wiesner DL, Smith KD, Jenkins MK, et al.Specialized regulatory T cells suppress pathologic type-2 helper T cell inflammation during pulmonary cryptococcosis[J]. Mycoses, 2014, 57(1): 20-24.
[17] 汪金林, 李时悦, 罗永峰, 等. 无免疫功能低下的肺隐球菌病患者 Th1/Th2 类细胞因子的变化[J]. 中华结核和呼吸杂志, 2013, 36(10): 751-755.
[18] Müller U, Stenzel W, Piehler D, et al.The role of macrophages in Il-4 receptor (il-4r)-dependent pathology in pulmonary cryptococcosis[J]. Mycoses, 2015, 58: 65-66.
[19] Huang J, Lan C, Li H, et al.Retrospective analysis of 117 chinese patients with pulmonary cryptococcosis[J]. Chest, 2016, 149(4): 124-124.
[20] 曹彬, 蔡柏蔷, 王辉, 等. 肺部真菌感染152例病原谱再评价[J]. 中华结核和呼吸杂志, 2007, 30(4): 279-283.
[21] 冯瑞枝, 林波淼, 梁文, 等. 肺隐球菌病的CT影像表现[J]. 临床肺科杂志, 2016, 21(11): 1986-1989.
[22] 谭国强, 龙晚生, 马雁秀, 等. 肺隐球菌病的 CT 诊断及病理对照[J]. 临床放射学杂志, 2013, 32(9): 1272-1275.
[23] 范碧君, 王葆青, 张含之, 等. 不同免疫状态肺隐球菌病临床特点分析[J]. 中国真菌学杂志, 2013, 8(4): 193-197.
[24] Miller KD, Mican JAM, Davey RT.Asymptomatic solitary pulmonary nodules due to cryptococcus neoformans in patients infected with human immunodeficiency virus[J]. Clin Infect Dis, 23(4):810-812.
[25] Batungwanayo J, Taelman H, Bogaerts J, et al.Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases[J]. Aids, 1994, 8(9):1271-1276.
[26] Visnegarwala F, Graviss EA, Lacke CE, et al.Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors[J]. Clin Infect Dis, 1998, 27(5):1231-1237.
[27] Hu Z, Xu C, Wei H, et al.Solitary cavitary pulmonary nodule may be a common CT finding in AIDS-associated pulmonary cryptococcosis[J]. Scand J Infect Dis, 2013, 45(5): 378-389.
[28] Hu Z, Chen J, Xu C.Radiological characteristics of pulmonary cryptococcosis in HIV-infected patients[J]. PLoS One, 2017, 12(3):e0173858.
[29] Morita S, Shirai T, Asada K, et al.Pulmonary cryptococcosis presenting with a large cavity[J]. Respirol Case Rep, 2014, 2(2): 61-63.
[30] Gunda DW, Bakshi FA, Rambau P, et al.Pulmonary cryptococcosis presenting as acute severe respiratory distress in a newly diagnosed HIV patient in Tanzania: a case report[J]. Clin Case Rep, 2015, 3(9): 749-752.
[31] Perfect JR, Dismukes WE, Dromer F, et al.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis, 2010, 50(3):291-322.
[32] Ariza J, Cobo J, Baraia-Etxaburu J, et al.Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)[J]. Enferm Infecc Microbiol Clin, 2017, 35(3):189-195.
[33] Liang Y, Shen Y, Zhang J, et al.Pulmonary cryptococcosis among 3 immunocompetent patients misdiagnosed as bacterial pneumonia and pulmonary tuberculosis[J]. CHEST, 2016, 149(4): 114-114.
[34] Shigeru K, Hiroshi K, Koichi I, et al.Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan.[J]. J Infect Chemo, 2015, 21(1):23-30.
[35] Chang WC, Tzao C, Hsu HH, et al.Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients[J]. Chest, 2006, 129(2):333-340.
[36] Hare SS, Souza CA, Bain G, et al.The radiological spectrum of pulmonary lymphoproliferative disease[J]. Br J Radiol, 2012, 85(1015):848-864.
[37] Restrepo CS, Martinez S, Lemos JA, et al.Imaging manifestations of Kaposi sarcoma.[J] Radiographics, 2006, 26(4):1169-1185.
[38] La Ferla L, Pinzone MR, Nunnari G, et al.Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era[J]. Eur Rev Med Pharmacol Sci, 2013, 17(17):2354-65.
[39] Muldoon EG, Sharman A, Page I, et al.Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis[J]. BMC PulmMed, 2016, 16(1):123.
[40] Makino Y, Nishiyama O, Sano H, et al.Cavitary Pulmonary Cryptococcosis with an Aspergillus Fungus Ball[J]. Intern Med, 2014, 53(23): 2737-2739.
[41] Chitasombat M, Supparatpinyo K.Penicillium marneffei infection in immunocompromised host[J]. Cur Fung Infect Rep, 2013, 7(1):44-50.
[42] Kisembo HN, Boon SD, Davis JL, et al.Chest radiographic findings of pulmonary tuberculosis in severely immunocompromised patients with the human immunodeficiency virus[J]. Br J Radiol, 2012, 85(1014):e130-139.
[43] Iribarren JA, Rubio R, Aguirrebengoa K, et al.Executive summary: prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients[J] Enf Inf Micro Clin, 2016, 34(8):517-523.